-
Je něco špatně v tomto záznamu ?
Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development
A. Camandona, A. Gagliardi, N. Licheri, S. Tarallo, G. Francescato, E. Budinska, M. Carnogurska, B. Zwinsová, B. Martinoglio, L. Franchitti, G. Gallo, S. Cutrupi, M. De Bortoli, B. Pardini, A. Naccarati, G. Ferrero
Status neindexováno Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
825410
Horizon 2020
825410
Horizon 2020
825410
Horizon 2020
825410
Horizon 2020
825410
Horizon 2020
24882
Associazione Italiana per la Ricerca sul Cancro
NLK
BioMedCentral
od 2013-12-01
BioMedCentral Open Access
od 2013
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
Springer Nature OA/Free Journals
od 2013-12-01
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Early detection of colorectal cancer (CRC) significantly improves its management and patients' survival. Circular RNAs (circRNAs) are peculiar covalently closed transcripts involved in gene expression modulation whose dysregulation has been extensively reported in CRC cells. However, little is known about their alterations in the early phases of colorectal carcinogenesis. METHODS: In this study, we performed an integrative analysis of circRNA profiles in RNA-sequencing (RNA-Seq) data of 96 colorectal cancers, 27 adenomas, and matched adjacent mucosa tissues. We also investigated the levels of cognate linear transcripts and those of regulating RNA-binding proteins (RBPs). Levels of circRNA-interacting microRNAs (miRNAs) were explored by integrating data of small RNA-Seq performed on the same samples. RESULTS: Our results revealed a significant dysregulation of 34 circRNAs (paired adj. p < 0.05), almost exclusively downregulated in tumor tissues and, prevalently, in early disease stages. This downregulation was associated with decreased expression of circRNA host genes and those encoding for RBPs involved in circRNA biogenesis, including NOVA1, RBMS3, and MBNL1. Guilt-by-association analysis showed that dysregulated circRNAs correlated with increased predicted activity of cell proliferation, DNA repair, and c-Myc signaling pathways. Functional analysis showed interactions among dysregulated circRNAs, RBPs, and miRNAs, which were supported by significant correlations among their expression levels. Findings were validated in independent cohorts and public datasets, and the downregulation of circLPAR1(2,3) and circLINC00632(5) was validated by ddPCR. CONCLUSIONS: These results support that multiple altered regulatory mechanisms may contribute to the reduction of circRNA levels that characterize early colorectal carcinogenesis.
Candiolo Cancer Institute FPO IRCCS Candiolo Turin 10060 Italy
Department of Clinical and Biological Sciences University of Torino Turin 10100 Italy
Department of Colorectal Surgery Clinica S Rita Vercelli 13100 Italy
Department of Surgery La Sapienza University of Rome Rome 00161 Italy
Italian Institute for Genomic Medicine c o IRCCS Candiolo Turin 10060 Italy
RECETOX Faculty of Science Masaryk University Brno 61137 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008390
- 003
- CZ-PrNML
- 005
- 20250422095748.0
- 007
- ta
- 008
- 250408s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s40364-025-00744-8 $2 doi
- 035 __
- $a (PubMed)39980011
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Camandona, Alessandro $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
- 245 10
- $a Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development / $c A. Camandona, A. Gagliardi, N. Licheri, S. Tarallo, G. Francescato, E. Budinska, M. Carnogurska, B. Zwinsová, B. Martinoglio, L. Franchitti, G. Gallo, S. Cutrupi, M. De Bortoli, B. Pardini, A. Naccarati, G. Ferrero
- 520 9_
- $a BACKGROUND: Early detection of colorectal cancer (CRC) significantly improves its management and patients' survival. Circular RNAs (circRNAs) are peculiar covalently closed transcripts involved in gene expression modulation whose dysregulation has been extensively reported in CRC cells. However, little is known about their alterations in the early phases of colorectal carcinogenesis. METHODS: In this study, we performed an integrative analysis of circRNA profiles in RNA-sequencing (RNA-Seq) data of 96 colorectal cancers, 27 adenomas, and matched adjacent mucosa tissues. We also investigated the levels of cognate linear transcripts and those of regulating RNA-binding proteins (RBPs). Levels of circRNA-interacting microRNAs (miRNAs) were explored by integrating data of small RNA-Seq performed on the same samples. RESULTS: Our results revealed a significant dysregulation of 34 circRNAs (paired adj. p < 0.05), almost exclusively downregulated in tumor tissues and, prevalently, in early disease stages. This downregulation was associated with decreased expression of circRNA host genes and those encoding for RBPs involved in circRNA biogenesis, including NOVA1, RBMS3, and MBNL1. Guilt-by-association analysis showed that dysregulated circRNAs correlated with increased predicted activity of cell proliferation, DNA repair, and c-Myc signaling pathways. Functional analysis showed interactions among dysregulated circRNAs, RBPs, and miRNAs, which were supported by significant correlations among their expression levels. Findings were validated in independent cohorts and public datasets, and the downregulation of circLPAR1(2,3) and circLINC00632(5) was validated by ddPCR. CONCLUSIONS: These results support that multiple altered regulatory mechanisms may contribute to the reduction of circRNA levels that characterize early colorectal carcinogenesis.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gagliardi, Amedeo $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
- 700 1_
- $a Licheri, Nicola $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
- 700 1_
- $a Tarallo, Sonia $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
- 700 1_
- $a Francescato, Giulia $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy
- 700 1_
- $a Budinska, Eva $u RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic
- 700 1_
- $a Carnogurska, Martina $u RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic
- 700 1_
- $a Zwinsová, Barbora $u RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic
- 700 1_
- $a Martinoglio, Barbara $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
- 700 1_
- $a Franchitti, Lorenzo $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
- 700 1_
- $a Gallo, Gaetano $u Department of Surgery, "La Sapienza" University of Rome, Rome, 00161, Italy $u Department of Colorectal Surgery, Clinica S. Rita, Vercelli, 13100, Italy
- 700 1_
- $a Cutrupi, Santina $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
- 700 1_
- $a De Bortoli, Michele $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
- 700 1_
- $a Pardini, Barbara $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
- 700 1_
- $a Naccarati, Alessio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
- 700 1_
- $a Ferrero, Giulio $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy. giulio.ferrero@unito.it $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy. giulio.ferrero@unito.it
- 773 0_
- $w MED00205975 $t Biomarker research $x 2050-7771 $g Roč. 13, č. 1 (2025), s. 30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39980011 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20250422095749 $b ABA008
- 999 __
- $a ok $b bmc $g 2306361 $s 1245465
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 13 $c 1 $d 30 $e 20250220 $i 2050-7771 $m Biomarker research $n Biomark Res $x MED00205975
- GRA __
- $a 825410 $p Horizon 2020
- GRA __
- $a 825410 $p Horizon 2020
- GRA __
- $a 825410 $p Horizon 2020
- GRA __
- $a 825410 $p Horizon 2020
- GRA __
- $a 825410 $p Horizon 2020
- GRA __
- $a 24882 $p Associazione Italiana per la Ricerca sul Cancro
- LZP __
- $a Pubmed-20250408